Our Team

Dennis Nash

President, CEO, & Co-Founder

Dennis has led high growth teams at IBM, Oracle, E&Y Consulting, and several successful new technology startups.  His business development experience helped rapidly get new products commercialized and ramped up sales to millions to hundreds of millions $ per year.  Several of the companies had sizable exit events.  Dennis has been instrumental in getting executives, finance, marketing, sales, operations, and engineering aligned to engage targeted customers to deliver high value that obtain obtained high growth and shareholder value.  He has also managed two successful business restructuring projects. His quality systems background blended with feedback from dozens of mental health, medical, and bio-systems experts plus patient health advocates identified challenges brought the need for N-of-1 science to the forefront.  He is a Mechanical Engineer with minor in business from MIT that helps teams succeed by delivering world class solutions to previously big unmet needs and leveraging breakthrough technologies. 

Steven Schwartz, Ph.D.

Chief Science Advisor & Co-Founder

Steven has been involved in healthcare delivery and research for 30 years and has led outcomes evaluation and clinical trial coordination in a variety of settings including healthcare delivery systems, digital health technology, data analytics and the pharmaceutical industries. As part of the Behavioral Science Team that architected and evaluated the suite of HealthMedia digital health coaching products prior to, during, and after the company’s acquisition by Johnson and Johnson in 2008, Dr. Schwartz has been part of the digital innovation curve in healthcare for many years. He has published extensively in peer review science and industry trade publications. He has spoken on key health and technology topics locally, nationally and internationally. As a Boarded Clinical Psychologist, Dr. Schwartz has significant theoretical and practical expertise in (Cognitive) Behavioral Psychology, Learning Theory, Positive Psychology, Behavioral Economics, Clinical Trials Design, Program Evaluation, Human-Centered and Instructional Design, Gamification and N-of-1 Individual Science methodology. Dr. Schwartz is co-inventor on pending patent to enhance personalized evidenced-based medical and non-pharmaceutical micro-treatments. The invention leverages predictive population statistics, AI, wearable sensors, and N-of-1 simple-to-understand accurate personalized IndividuALLytics Quotients™ to give medical professionals new level of personalized predictive analytics cost-effectively to aid improved productive patient conversations and better outcomes. This cloud-based solution can easily be added to health and chronic disease apps to power better outcome results and improve measurable value delivered. 

Brigid Byrd, Ph.D.

Bio-psychosocial Health Consultant and Project Manager

Research in Kinesiology with a specialization in Sport and Exercise Psychology from Wayne State University. Throughout her academic career she has developed expertise in the biopsychosocial model of health, behavioral science as applied to sport and exercise settings, measurement assessment and research methodology. Brigid has experience assessing psychosocial factors associated with exercise and health antecedents and outcomes in various populations including elderly adults, disabled athletes, NCAA Division I athletes, novice exercisers, and underserved children. Her expertise aligns with IndividuALLytics’ goal of providing best practices regarding exercise and psychosocial measurements to enhance digital health applications. 

Max Hamilton

Computer Scientist

Experience cloud programmer and software design specialist. He is currently finishing up his Bachelor of Computer Science Engineering with a Minor in Mathematics from the University of Michigan. His main focus is in artificial intelligence, although he also has an interest in medical applications. He has worked on projects to detect cancer in brain scans and participated in a Public Health Hackathon aimed at improving access to care in Metro Detroit communities. Max also has experience with utilizing AWS cloud services to connect multiple data sources and applications into a single product.. 

Dr. Richard Bedrosian

Clinical Psychologist

With over 40 years of experience. He has been a pioneer in developing digital programs for improving physical and mental health. He was founder/CEO of MySelfHelp.com, which offered online programs for mental health problems. He was Principal Investigator on seven SBIR from the National Institutes of Health, later serving as ad hoc reviewer for SBIR applications to NIH. In 2006, MySelfHelp.com, was acquired by HealthMedia, which was acquired by Johnson and Johnson in 2008. From 2006 to 2008, Dr. Bedrosian served as Director of Behavioral Health for HealthMedia, continuing in that role for J&J Health & Wellness Solutions until 2016. Dr. Bedrosian currently consults with companies developing and commercializing innovative products targeting behavioral health, wellness, and disease management. Dr. Bedrosian is an Instructor in Psychiatry at the University of Massachusetts Medical School, where he teaches cognitive-behavior therapy. He is author of numerous publications focused on depression, eating disorders, and digital coaching and has taught and mentored therapist at the national and international level. 

Jeremy Albright, Ph.D.

Statistics and Data Visualization Advisor

Founder and CEO of a data science consulting firm. He has over ten years of experience working with clients from business, finance, government, and academia to glean actionable insights from complicated data. For example: (1) a multinational market research firm relied on slow, error-prone process of manually creating and summarizing data collected from its clients, so Jeremy led development of an app to automate the data management and certain analytic steps, reducing tasks that took days down to seconds and saving the company tens of thousands of dollars in labor costs per year; (2) New Jersey-based hedge fund sought assistance determining optimal machine learning algorithm to predict movements in US equities, so Jeremy developed a deep learning-based model that has consistently outperformed the larger market for nearly two years, including during periods of high volatility, and helping the fund continue to attract new investors; and (3) Legal counsel required expert statistical testimony on behalf of a whistle-blower in a case alleging fraudulent Medicare billing. Albright’s data analysis and opinions were used in negotiations that led to a $35 million settlement favoring the whistle-blower. 

Dave Crosbee

Managing Director, Pharmaceutical Innovation

Daniel’s competencies include thought leader development and engagement, strategic planning, brand differentiation, direct to consumer advertising and customer retention. Dave is adept at analyzing the pharma and provider marketplace as it relates to mHealth initiatives to determine issues, needs, opportunities, desires and concerns. Dave’s accomplishments include the development of the Restasis direct to consumer advertising campaign, development of the Restless Leg Syndrome market for Glaxo’s brand Requip, the launch of Glaxo’s brand Zyban for smoking cessation and consulting with Allergan Pharmaceuticals to help shape their marketing strategy for several Botox’s therapeutic indications including migraine and overactive bladder. Dave was one of the founders of HealthMedia, a spinoff from the University of Michigan that was the first company to apply science-based behavior change coupled with the ability to personally tailor messaging on a mass scale. 

Janet Greenhut, MD, MPH

Tele-Doctor and Chronic Disease Prevention Lead

Janet , is a physician with 20 years of clinical experience in primary care and preventive medicine and 17 years of experience developing digital health coaching programs for physical and mental health. Her clinical experience includes working for the US Public Health Service in an underserved area and is maintaining a private practice in Ann Arbor, Michigan. She worked for HealthMedia starting in 1999 helping to develop a suite of innovative online health behavior change and disease management programs. She continued with the company as Medical Researcher and Consultant through its acquisition by Johnson & Johnson in 2008 until 2012. In 2013-2014, Dr. Greenhut worked for the Health Management Research Center at the University of Michigan developing a health risk assessment. She returned to J&J Health and Wellness Solutions in 2014-2017 as Medical Consultant. In 2018, Dr. Greenhut co-founded a nonprofit company, Narrative Dimensions, which offers workshops for people who are dealing with the challenges of chronic illness.

Collin Garstang

Chief Marketing Officer

Collin has led marketing and sales growth strategies in solar, software, engineering, life science, and manufacturing industries. He has helped companies grow in difficult times and despite limited resources as a veteran in marketing and sales with a focus on providing an organized and disciplined approach to integrating both into the overall business plan. He has successfully led all aspects of companies’ growth, including marketing, sales, business planning and development, major account penetration, channel expansion, marketing communications and recruiting. In addition, he has managed change with marketing and sales teams, directed strategic growth plans, integrated product diversification and initiated strategic global sales realignment to increase competitive position. Previously, he held a variety of domestic and international marketing and sales executive positions with General Electric, Gates Energy Products, W.R. Grace, Raybestos-Manhattan, United Solar Systems and a HP reseller. He has a degree in Marketing from the University of Massachusetts. 

Dr. Gordon Guyatt

Evidence-Based Medicine and N-of-1 Science Advisor

Gordon is a McMaster University Distinguished Professor. His work has focused on Evidence-based Medicine and promoting high quality health care without financial barriers for all Canadians; his Order of Canada citation acknowledges both contributions. He has been honored as Canadian Institute of Health Research researcher of year and a member of the Canadian Medical Hall of Fame. He presents on these topics internationally and he is cited often on N-of-1 science and evidence-based medicine.

Neal Fairbanks, CIO

Technical Advisor

Neal is a Senior Software Product Development Leader. He is an experienced enterprise software developer and manager with product development, SaaS, Cloud, HIPAA, high security, AI/big data, and mobile expertise. Neal manages programming team to hit key quality and time milestones. For example, his team supported implementing medical application with one of the first Microsoft SQLserver implementations that was truly HIPAA compliant personal information management system for a client.

David Weaver

Medical Device Business Development Advisor

David has managed the launch of numerous products into the life sciences global marketplace for over 30 years as a business development, sales and marketing executive. He has helped companies raise angel, VC and public (IPO) capital to take their products/services from concept to the commercial market. After 10 years with a J&J company, he was recruited to conduct a turn-around of a Warner-Lambert division in a flat market which was completed in one year.